Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
2.490
-0.070 (-2.73%)
At close: Dec 5, 2025, 4:00 PM EST
2.480
-0.010 (-0.40%)
After-hours: Dec 5, 2025, 7:57 PM EST
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $117.35 million as of December 5, 2025. Its market cap has increased by 115.44% in one year.
Market Cap
117.35M
Enterprise Value
-45.25M
1-Year Change
115.44%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $117.35M, a decrease of -78.30%. That is a compound annual growth rate of -30.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 117.35M | 50.91% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |